Visionary Horizons’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-10,283
Closed -$476K 114
2025
Q2
$476K Sell
10,283
-140
-1% -$6.87K 0.3% 66
2025
Q1
$636K Sell
10,423
-1,796
-15% -$105K 0.45% 40
2024
Q4
$691K Sell
12,219
-353
-3% -$19.7K 0.45% 36
2024
Q3
$650K Buy
12,572
+50
+0.4% +$2.35K 0.44% 39
2024
Q2
$520K Hold
12,522
0.38% 49
2024
Q1
$605K Hold
12,522
0.47% 33
2023
Q4
$643K Buy
+12,522
New +$657K 0.52% 28

Other funds holding BMY

Visionary Horizons's BMY Position: Q3 2025 in Review

Visionary Horizons sold out of Bristol-Myers Squibb (BMY) in Q3 2025, closing a stake of 10,283 shares — an estimated $476K sold.

Visionary Horizons first reported a position in BMY in Q4 2023 and held it in 7 quarters. The position peaked at $691K in Q4 2024. 2,267 funds tracked by Wall St. Rank hold BMY as of Q3 2025.

  • Visionary Horizons reported no remaining Bristol-Myers Squibb position as of Q3 2025 after selling out during the quarter.
  • Visionary Horizons sold 10,283 Bristol-Myers Squibb shares in Q3 2025, an estimated $476K.
  • Visionary Horizons first reported a position in Bristol-Myers Squibb in Q4 2023 and held it in 7 quarters.
  • Visionary Horizons's Bristol-Myers Squibb position peaked at $691K in Q4 2024.
  • 2,267 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2025.

Based on Visionary Horizons's 13F filing for Q3 2025, filed 23 Oct 2025.